Jump to Main Content

Highlights of ASH in North America

Join global hematology leaders at Highlights of ASH in North America, a two-day program offered in multiple locations, to explore and discuss the most influential and novel research presented at the latest ASH annual meeting.

Highlights of ASH in North America




“Connecting with colleagues outside my particular area of focus within hematology has been very rewarding. Highlights of ASH is a great place to break out of my comfort zone and keep me up to date on the exciting advances in our field.”

Tyler W. Buckner, MD, MSc / University of Colorado School of Medicine
HOA_Speaker
HOA_NA_Meeting

Cutting-edge Research from Across Disciplines

Hear the most influential and novel research in malignant and classical hematology shared at the latest ASH annual meeting.

 

Instant Insights

Ask questions and get feedback from top hematology experts in real time.

 

Real Advice You Can Use

Gain insight into local and regional standards of care. Discover how emerging technology can enhance your practice.

 

Meet Experts in Your Field

Network with colleagues of all career stages and form connections in your field.

 

Earn CME credits

Attendees can earn continuing medical education (CME) credits for physicians, while non-physicians and other health care professionals may receive a Certificate of Completion.

Meeting Information





Program Schedule

This program is curated for hematologists, oncologists, fellows and trainees, allied health professionals, advanced practice providers, and hematopathologists. The following session topics correspond to the 2027 Highlights of ASH in North America and are subject to change. The program schedule is identical for all 2027 Highlights of ASH North America locations.

11:00 a.m. Registration and Exhibits Open (Lunch provided)
11:45 p.m. Welcome and Introductions
12:00 p.m. Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Chronic Myeloid Leukemia
12:45 p.m. Indolent Lymphoma and Chronic Lymphocytic Leukemia
1:30 p.m. Aggressive Lymphoma
2:15 p.m.  Panel Discussion 
2:45 p.m.  Coffee Break and Exhibits Open 
3:00 p.m. Bleeding Disorders
3:45 p.m. Thrombosis
4:30 p.m. Women's Health and Iron
5:15 p.m.  Panel Discussion 
5:45 p.m.  Highlights of ASH Day 1 Program Adjournment 
6:00 p.m.  Satellite Symposia 
7:00 a.m. Registration and Exhibits Open
(Breakfast provided)
7:45 a.m. Welcome and Introductions
8:00 a.m. Plasma Cell Disorders and Multiple Myeloma
8:45 a.m. Transplantation
9:30 a.m. Complications of Novel Therapies
10:15 a.m.  Panel Discussion 
10:45 a.m.  Coffee Break and Exhibits Open 
11:00 a.m. Acute Lymphoblastic Leukemia
11:45 a.m. Acute Myeloid Leukemia
12:30 p.m.   Panel Discussion
1:00 p.m.  Lunch with the Experts (All Speakers and Attendees) 
2:15 p.m. Hemoglobinopathies and Red Blood Cell Disorders
3:00 p.m. Consultative Hematology
3:45 p.m. Beyond the Acute Illness
4:30 p.m.  Panel Discussions
5:00 p.m.  Closing Remarks and Adjournment 

Acknowledgments

Thank you to our esteemed committee of experts dedicated to advancing the development of this meeting, our State Society Partners, and our company partners for providing educational grants in support of the 2026 Highlights of ASH in North America.

Highlights of ASH Steering Subcommittee

  • Alison Walker, MD, MBA, MPH, Chair, Moffitt Cancer Center
  • Maureen Okam Achebe, MD, MPH, Brigham and Women’s Hospital 
  • Jason Freed, MD, Beth Israel Deaconess Medical Center
  • Cyrus C. Hsia, MD, FRCPC, London Health Sciences Centre
  • Manali Kamdar, MD, University of Colorado
  • Mary Ann Knovich, MD, Atrium Health Levine Cancer Institute​
  • John C. Molina, MD, EdM, Cleveland Clinic
  • Ruben Niesvizky, MD, Weill Cornell Medicine
  • Rachel P. Rosovsky, MD, Massachusetts General Hospital
  • Eric Tse, MBBS, PhD, Hong Kong University
  • Robert Zeiser, MD, University of Freiburg